ResearcherMassachusetts Institute of TechnologyNo recent work listed
Xing Huang
Matched on ORCID iD 0000-0002-6055-5089; OpenAlex author ID A5052315550, A5101684747. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers
Papers 5
- Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single cen… Co-author DOI 10.3389/fonc.2022.966256↗
- Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection without preoperative neoadjuvant treatm… Co-author DOI 10.3389/fsurg.2022.992641↗
- EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. Co-author DOI 10.1097/md.0000000000027103↗
- Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review). Co-author DOI 10.3892/ijo.2021.5281↗
- Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer. Co-author DOI 10.1021/acs.nanolett.7b04043↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Li Mao · 3 shared papers, 2021–2022 · strength 0.50
- Paper Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review). DOI 10.3892/ijo.2021.5281↗
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103↗
- Zuowei Wu · 3 shared papers, 2021–2022 · strength 0.50
- Paper Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection… DOI 10.3389/fsurg.2022.992641↗
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103↗
- Zihe Wang · 3 shared papers, 2021–2022 · strength 0.50
- Paper Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection… DOI 10.3389/fsurg.2022.992641↗
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103↗
- Bole Tian · 2 shared papers, 2022 · strength 0.35
- Paper Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection… DOI 10.3389/fsurg.2022.992641↗
- Paper Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer pa… DOI 10.3389/fonc.2022.966256↗
- Chao Wu · 2 shared papers, 2021–2022 · strength 0.31
- Bole Tian · 1 shared paper, 2021 · strength 0.19
- Pengcheng Zhao · 1 shared paper, 2022 · strength 0.19
- Pengcheng Zhao · 1 shared paper, 2022 · strength 0.16
- Li Wang · 1 shared paper, 2022 · strength 0.16
- Bole Tian · 1 shared paper, 2021 · strength 0.15
- Yingjie Yu · 1 shared paper, 2018 · strength 0.08
- Paiman Peter Ghoroghchian · 1 shared paper, 2018 · strength 0.08
- Zhimin Tao · 1 shared paper, 2018 · strength 0.08
- Mandar Deepak Muzumdar · 1 shared paper, 2018 · strength 0.08
- Tyler Jacks · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.